Home

Karen Valentine

CIK 1437152 · See Remarks · last filed 2021-07-19

Karen Valentine is a corporate insider who has filed 66 SEC Form 4 insider transactions across 2 companies since 2008. Across all open-market trades the lifetime net is −$3.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $35.2K across reported positions. 52 SEC filings were submitted jointly with AGENUS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$35.2K

Companies

2

Total Filings

66

Lifetime Open-Market Net

-$3.44M

Filer Profile

Reported Address
C/O ANTIGENICS INC.
3 FORBES RD
LEXINGTON, MA 02421
Related Filers
AGENUS INC — 52 joint filings, latest 2018-06-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted See Remarks 0 $33.99 $0 -$3.30M 14 2021-02-18
AGEN Chief Legal Officer and GC 5,076 $6.94 $35.2K -$140.0K 51 2018-06-22

Recent Filings

66 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-19 — Disp (D) — $0
2021-02-18 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Grant (A) — $0 EDGAR
2021-01-20 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$386.6K EDGAR
2020-05-07 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$501.4K EDGAR
2020-04-29 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$11.5K EDGAR
2020-04-22 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$17.5K EDGAR
2020-04-20 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$120.6K EDGAR
2020-04-13 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$16.7K EDGAR
2020-03-11 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Mixed — -$14.4K EDGAR
2020-02-18 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 66
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.